Back to Search Start Over

Effect of fluid loading on left ventricular volume and stroke volume variability in patients with end-stage renal disease: a pilot study.

Authors :
Hirotsugu Kanda
Yuji Hirasaki
Takafumi Iida
Megumi Kanao-Kanda
Yuki Toyama
Takayuki Kunisawa
Hiroshi Iwasaki
Kanda, Hirotsugu
Hirasaki, Yuji
Iida, Takafumi
Kanao-Kanda, Megumi
Toyama, Yuki
Kunisawa, Takayuki
Iwasaki, Hiroshi
Source :
Therapeutics & Clinical Risk Management; 2015, Vol. 11, p1619-1625, 7p
Publication Year :
2015

Abstract

<bold>Purpose: </bold>The aim of this study was to investigate fluid loading-induced changes in left ventricular end-diastolic volume (LVEDV) and stroke volume variability (SVV) in patients with end-stage renal disease (ESRD) using real-time three-dimensional transesophageal echocardiography and the Vigileo-FloTrac system.<bold>Patients and Methods: </bold>After obtaining ethics committee approval and informed consent, 28 patients undergoing peripheral vascular procedures were studied. Fourteen patients with ESRD on hemodialysis (HD) were assigned to the HD group and 14 patients without ESRD were assigned to the control group. Institutional standardized general anesthesia was provided in both groups. SVV was measured using the Vigileo-FloTrac system. Simultaneously, a full-volume three-dimensional transesophageal echocardiography dataset was acquired to measure LVEDV, left ventricular end-systolic volume, and left ventricular ejection fraction. Measurements were obtained before and after loading 500 mL hydroxyethyl starch over 30 minutes in both groups.<bold>Results: </bold>In the control group, intravenous colloid infusion was associated with a significant decrease in SVV (13.8%±2.6% to 6.5%±2.6%, P<0.001) and a significant increase in LVEDV (83.6±23.4 mL to 96.1±28.8 mL, P<0.001). While SVV significantly decreased after infusion in the HD group (16.2%±6.0% to 6.2%±2.8%, P<0.001), there was no significant change in LVEDV.<bold>Conclusion: </bold>Our preliminary data suggest that fluid responsiveness can be assessed not by LVEDV but also by SVV due to underlying cardiovascular pathophysiology in patients with ESRD. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
11766336
Volume :
11
Database :
Complementary Index
Journal :
Therapeutics & Clinical Risk Management
Publication Type :
Academic Journal
Accession number :
110803918
Full Text :
https://doi.org/10.2147/TCRM.S91296